Profile | GDS5420 / 224693_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 258.13 | 56 |
GSM1296119 | B_lesional_pre-dose | 924.04 | 78 |
GSM1296076 | C_lesional_pre-dose | 818.25 | 76 |
GSM1296092 | D_lesional_pre-dose | 624.58 | 72 |
GSM1296103 | E_lesional_pre-dose | 404.65 | 64 |
GSM1296078 | F_lesional_pre-dose | 655.86 | 73 |
GSM1296107 | G_lesional_pre-dose | 849.05 | 77 |
GSM1296109 | H_lesional_pre-dose | 769.54 | 75 |
GSM1296080 | I_lesional_pre-dose | 144.48 | 49 |
GSM1296090 | J_lesional_pre-dose | 769.05 | 75 |
GSM1296074 | K_lesional_pre-dose | 805.63 | 76 |
GSM1296111 | L_lesional_pre-dose | 1294.39 | 83 |
GSM1296099 | M_lesional_pre-dose | 592.49 | 70 |
GSM1296086 | O_lesional_pre-dose | 482.22 | 68 |
GSM1296117 | P_lesional_pre-dose | 1306.91 | 84 |
GSM1296113 | Q_lesional_pre-dose | 975.53 | 79 |
GSM1296096 | R_lesional_pre-dose | 425.86 | 65 |
GSM1296105 | S_lesional_pre-dose | 265.78 | 56 |
GSM1296098 | T_lesional_pre-dose | 243.75 | 55 |
GSM1296101 | U_lesional_pre-dose | 315.95 | 59 |
GSM1296121 | V_lesional_pre-dose | 842.31 | 77 |
GSM1296088 | W_lesional_pre-dose | 332.43 | 61 |
GSM1296082 | X_lesional_pre-dose | 628 | 72 |
GSM1296115 | Y_lesional_pre-dose | 1078.88 | 80 |
GSM1296084 | Z_lesional_pre-dose | 493.03 | 67 |
GSM1296072 | B_lesional_day8 | 933.39 | 78 |
GSM1296069 | L_lesional_day8 | 1260.11 | 83 |
GSM1296071 | P_lesional_day8 | 896.27 | 78 |
GSM1296070 | Y_lesional_day8 | 1110.14 | 81 |
GSM1296073 | V_lesional_day8 | 838.36 | 77 |
GSM1296034 | A_lesional_day15 | 127.69 | 44 |
GSM1296041 | G_lesional_day15 | 989.28 | 79 |
GSM1296035 | R_lesional_day15 | 363.41 | 62 |
GSM1296038 | U_lesional_day15 | 592.12 | 71 |
GSM1296047 | B_lesional_day15 | 763.85 | 75 |
GSM1296039 | E_lesional_day15 | 601.03 | 71 |
GSM1296042 | H_lesional_day15 | 1137.03 | 81 |
GSM1296043 | L_lesional_day15 | 1211.35 | 83 |
GSM1296037 | M_lesional_day15 | 326.34 | 60 |
GSM1296046 | P_lesional_day15 | 1282.39 | 84 |
GSM1296044 | Q_lesional_day15 | 918.37 | 78 |
GSM1296045 | Y_lesional_day15 | 1158.04 | 82 |
GSM1296025 | C_lesional_day15 | 253.03 | 57 |
GSM1296033 | D_lesional_day15 | 400.63 | 64 |
GSM1296027 | I_lesional_day15 | 247.8 | 57 |
GSM1296032 | J_lesional_day15 | 437.67 | 65 |
GSM1296024 | K_lesional_day15 | 199.83 | 53 |
GSM1296031 | W_lesional_day15 | 359.05 | 61 |
GSM1296028 | X_lesional_day15 | 456.37 | 66 |
GSM1296029 | Z_lesional_day15 | 284.71 | 58 |
GSM1296026 | F_lesional_day15 | 208.96 | 54 |
GSM1296030 | O_lesional_day15 | 218.2 | 55 |
GSM1296040 | S_lesional_day15 | 229.9 | 54 |
GSM1296036 | T_lesional_day15 | 226.31 | 53 |
GSM1296048 | V_lesional_day15 | 857.43 | 77 |
GSM1296059 | A_lesional_day43 | 337.43 | 61 |
GSM1296066 | G_lesional_day43 | 1129.47 | 81 |
GSM1296060 | R_lesional_day43 | 488.29 | 67 |
GSM1296063 | U_lesional_day43 | 882.96 | 77 |
GSM1296064 | E_lesional_day43 | 883.67 | 77 |
GSM1296067 | H_lesional_day43 | 618.2 | 71 |
GSM1296062 | M_lesional_day43 | 285.51 | 58 |
GSM1296068 | Q_lesional_day43 | 879.52 | 77 |
GSM1296050 | C_lesional_day43 | 566.37 | 70 |
GSM1296057 | D_lesional_day43 | 584.09 | 70 |
GSM1296052 | I_lesional_day43 | 266.94 | 58 |
GSM1296054 | J_lesional_day43 | 238.34 | 54 |
GSM1296049 | K_lesional_day43 | 192.14 | 52 |
GSM1296055 | W_lesional_day43 | 483 | 67 |
GSM1296053 | X_lesional_day43 | 146.62 | 47 |
GSM1296058 | Z_lesional_day43 | 372.41 | 63 |
GSM1296051 | F_lesional_day43 | 557.44 | 70 |
GSM1296056 | O_lesional_day43 | 567.69 | 70 |
GSM1296065 | S_lesional_day43 | 770.43 | 75 |
GSM1296061 | T_lesional_day43 | 213.84 | 53 |
GSM1296095 | A_non-lesional_pre-dose | 641.91 | 72 |
GSM1296120 | B_non-lesional_pre-dose | 955.03 | 79 |
GSM1296077 | C_non-lesional_pre-dose | 320.32 | 61 |
GSM1296093 | D_non-lesional_pre-dose | 232.22 | 54 |
GSM1296104 | E_non-lesional_pre-dose | 724.74 | 74 |
GSM1296079 | F_non-lesional_pre-dose | 285.16 | 59 |
GSM1296108 | G_non-lesional_pre-dose | 742.29 | 74 |
GSM1296110 | H_non-lesional_pre-dose | 787.73 | 75 |
GSM1296081 | I_non-lesional_pre-dose | 78.6 | 39 |
GSM1296091 | J_non-lesional_pre-dose | 585.01 | 70 |
GSM1296075 | K_non-lesional_pre-dose | 728.07 | 74 |
GSM1296112 | L_non-lesional_pre-dose | 1119.52 | 82 |
GSM1296100 | M_non-lesional_pre-dose | 436.67 | 65 |
GSM1296087 | O_non-lesional_pre-dose | 353.37 | 63 |
GSM1296118 | P_non-lesional_pre-dose | 1105.58 | 81 |
GSM1296114 | Q_non-lesional_pre-dose | 975.68 | 79 |
GSM1296097 | R_non-lesional_pre-dose | 582.7 | 70 |
GSM1296106 | S_non-lesional_pre-dose | 474.54 | 66 |
GSM1296102 | U_non-lesional_pre-dose | 240.97 | 54 |
GSM1296122 | V_non-lesional_pre-dose | 722.82 | 74 |
GSM1296089 | W_non-lesional_pre-dose | 353.86 | 61 |
GSM1296083 | X_non-lesional_pre-dose | 175.61 | 50 |
GSM1296116 | Y_non-lesional_pre-dose | 1116.89 | 81 |
GSM1296085 | Z_non-lesional_pre-dose | 302.07 | 59 |